from Reuters Video: Business https://ift.tt/2Rk1WTp
Breakingviews TV: Drug dreams
Moderna’s hoped-for $8 bln IPO valuation is a rich antidote to the funk hitting tech stocks. Rob Cyran explains that although the biotech firm’s technology is promising, it has no drugs near commercial readiness. That’s all the more reason to grab the money while it can.
from Reuters Video: Business https://ift.tt/2Rk1WTp
from Reuters Video: Business https://ift.tt/2Rk1WTp
Subscribe to:
Post Comments (Atom)
-
In a major bureaucratic reshuffle, 30 joint secretaries (JSs) were appointed in different departments of central government on Monday. fro...
-
Prime Minister Narendra Modi today embarked on Mission Suth India today with plans to inaugurate a slew of projects and address public meeti...
-
Two suspected militants were arrested in Ramban district's Gool in Jammu and Kashmir on Monday. A joint operation was launched by Police...
No comments:
Post a Comment